Reference data : LOINC code

Filter


Clear filter

Results
104,672 results found
Loinc Number Component Property System Time aspect ScaleType MethodType Relat_nms loincStatus Long Common name answerList chngType DefinitionDescription dtLastCh exactCmspy exampleUnits exmplAnswers externalCopyrightNotice formula hl7FieldSubfieldId InpcPercentage ipccUnits loincClass loincFinal loincNum mapTo methodTyp molarMass naaccrId orderObs panelElements reference scope setRoot shortName source surveyQuestSrc surveyQuestText unitsRequired acssym relatedNames2 VersionLastChanged VersionFirstRelease ValidHL7AttachmentRequest PanelType AssociatedObservations EXTERNAL_COPYRIGHT_LINK HL7_ATTACHMENT_STRUCTURE CONSUMER_NAME EXAMPLE_UCUM_UNITS STATUS_REASON STATUS_TEXT CHANGE_REASON_PUBLIC COMMON_TEST_RANK COMMON_ORDER_RANK
54185-4 Caspofungin Susc Isolate Pt OrdQn Gradient strip   ACTIVE Caspofungin [Susceptibility] by Gradient strip   MIN DefinitionDescription                   ABXBACT   54185-4   Gradient strip     Both       0 Caspofungin Islt Grad strip       N   ANTIBIOTIC SUSCEPTIBILITIES; AST; Epsilometer; Estrip; E-strip; Grad strip; ID; Infectious Disease; InfectiousDisease; Islt; Isol; MIC; Minimum inhibitory concentration; Point in time; Random; Sus; Suscept; Susceptibilities; Susceptibility; Susceptibilty 2.56 2.27                     Feb 2016-removed "E-test" from the short and long names because the "ETEST" name is trademarked 0
54186-2 Posaconazole Susc Isolate Pt OrdQn Gradient strip   ACTIVE Posaconazole [Susceptibility] by Gradient strip   MIN DefinitionDescription                   ABXBACT   54186-2   Gradient strip     Both       0 Posaconazole Islt Grad strip       N   ANTIBIOTIC SUSCEPTIBILITIES; AST; Epsilometer; Estrip; E-strip; Grad strip; ID; Infectious Disease; InfectiousDisease; Islt; Isol; MIC; Minimum inhibitory concentration; Noxafil; Point in time; Random; Sus; Suscept; Susceptibilities; Susceptibility; Susceptibilty 2.56 2.27                     Feb 2016-removed "E-test" from the short and long names because the "ETEST" name is trademarked 0
54187-0 Posaconazole Susc Isolate Pt OrdQn MIC   ACTIVE Posaconazole [Susceptibility] by Minimum inhibitory concentration (MIC)   MIN DefinitionDescription                   ABXBACT   54187-0   MIC     Both       0 Posaconazole Islt MIC       N   ANTIBIOTIC SUSCEPTIBILITIES; AST; ID; Infectious Disease; InfectiousDisease; Islt; Isol; Minimum inhibitory concentration; Noxafil; Point in time; Random; Sus; Suscept; Susceptibilities; Susceptibility; Susceptibilty 2.73 2.27                       0
54188-8 Posaconazole Susc Isolate Pt OrdQn     ACTIVE Posaconazole [Susceptibility]   MIN DefinitionDescription                   ABXBACT   54188-8         Both       0 Posaconazole Susc Islt       N   ANTIBIOTIC SUSCEPTIBILITIES; AST; ID; Infectious Disease; InfectiousDisease; Islt; Isol; Noxafil; Point in time; Random; Sus; Suscept; Susceptibilities; Susceptibility; Susceptibilty 2.27 2.27                       0
54189-6 Posaconazole Susc Isolate Pt OrdQn Agar diffusion   ACTIVE Posaconazole [Susceptibility] by Disk diffusion (KB)   MIN DefinitionDescription                   ABXBACT   54189-6   Agar diffusion     Both       0 Posaconazole Islt KB       N   ANTIBIOTIC SUSCEPTIBILITIES; AST; Disk diffusion; ID; Infectious Disease; InfectiousDisease; Islt; Isol; KB; Kirby-bauer; Noxafil; Point in time; Random; Sus; Suscept; Susceptibilities; Susceptibility; Susceptibilty 2.27 2.27                       0
5419-7 CD104 ACnc WBC Pt Qn     DEPRECATED Deprecated CD104 cells/100 cells in Blood   MIN DefinitionDescription                   CELLMARK   5419-7                 0 Deprecated CD104 WBC-aCnc           Arbitrary concentration; Beta 4; Beta 4 integrin chain; Beta4; Beta-4 integrin; CELL MARKERS; Leukocytes; Point in time; QNT; Quan; Quant; Quantitative; Random; TSP-1180; tumor specific protein 180 antigen; WBCs; White blood cells 2.69 1       AssociatedObservations EXTERNAL_COPYRIGHT_LINK HL7_ATTACHMENT_STRUCTURE CONSUMER_NAME EXAMPLE_UCUM_UNITS STATUS_REASON STATUS_TEXT CHANGE_REASON_PUBLIC COMMON_TEST_RANK COMMON_ORDER_RANK
54190-4 Temocillin Susc Isolate Pt OrdQn Gradient strip   ACTIVE Temocillin [Susceptibility] by Gradient strip   MIN DefinitionDescription                   ABXBACT   54190-4   Gradient strip     Both       0 Temocillin Islt Grad strip       N   ANTIBIOTIC SUSCEPTIBILITIES; AST; Epsilometer; Estrip; E-strip; Grad strip; ID; Infectious Disease; InfectiousDisease; Islt; Isol; MIC; Minimum inhibitory concentration; Nagaban; Point in time; Random; Sus; Suscept; Susceptibilities; Susceptibility; Susceptibilty; Temopen 2.56 2.27                     Feb 2016-removed "E-test" from the short and long names because the "ETEST" name is trademarked 0
54191-2 Cefotaxime+Sulbactam Susc Isolate Pt OrdQn     ACTIVE Cefotaxime+Sulbactam [Susceptibility]   MIN DefinitionDescription                   ABXBACT   54191-2         Both       0 Cefotaxime+Sulbac Susc Islt       N   ANTIBIOTIC SUSCEPTIBILITIES; AST; Claforan; ID; Infectious Disease; InfectiousDisease; Islt; Isol; Point in time; Random; Sulb; Sulbact; Sus; Suscept; Susceptibilities; Susceptibility; Susceptibilty 2.27 2.27                       0
54192-0 Cefotaxime+Sulbactam Susc Isolate Pt OrdQn MIC   ACTIVE Cefotaxime+Sulbactam [Susceptibility] by Minimum inhibitory concentration (MIC)   MIN DefinitionDescription                   ABXBACT   54192-0   MIC     Both       0 Cefotaxime+Sulbac Islt MIC       N   ANTIBIOTIC SUSCEPTIBILITIES; AST; Claforan; ID; Infectious Disease; InfectiousDisease; Islt; Isol; Minimum inhibitory concentration; Point in time; Random; Sulb; Sulbact; Sus; Suscept; Susceptibilities; Susceptibility; Susceptibilty 2.27 2.27                       0
54193-8 Cefotaxime+Sulbactam Susc Isolate Pt OrdQn Agar diffusion   ACTIVE Cefotaxime+Sulbactam [Susceptibility] by Disk diffusion (KB)   MIN DefinitionDescription                   ABXBACT   54193-8   Agar diffusion     Both       0 Cefotaxime+Sulbac Islt KB       N   ANTIBIOTIC SUSCEPTIBILITIES; AST; Claforan; Disk diffusion; ID; Infectious Disease; InfectiousDisease; Islt; Isol; KB; Kirby-bauer; Point in time; Random; Sulb; Sulbact; Sus; Suscept; Susceptibilities; Susceptibility; Susceptibilty 2.27 2.27                       0
54194-6 Mezlocillin+Sulbactam Susc Isolate Pt OrdQn     ACTIVE Mezlocillin+Sulbactam [Susceptibility]   MIN DefinitionDescription                   ABXBACT   54194-6         Both       0 Mezlocillin+Sulbac Susc Islt       N   ANTIBIOTIC SUSCEPTIBILITIES; AST; Baypen; ID; Infectious Disease; InfectiousDisease; Islt; Isol; Mezlin; Optocillin; Point in time; Random; Sulb; Sulbact; Sus; Suscept; Susceptibilities; Susceptibility; Susceptibilty 2.27 2.27                       0
54195-3 Mezlocillin+Sulbactam Susc Isolate Pt OrdQn MIC   ACTIVE Mezlocillin+Sulbactam [Susceptibility] by Minimum inhibitory concentration (MIC)   MIN DefinitionDescription                   ABXBACT   54195-3   MIC     Both       0 Mezlocillin+Sulbac Islt MIC       N   ANTIBIOTIC SUSCEPTIBILITIES; AST; Baypen; ID; Infectious Disease; InfectiousDisease; Islt; Isol; Mezlin; Minimum inhibitory concentration; Optocillin; Point in time; Random; Sulb; Sulbact; Sus; Suscept; Susceptibilities; Susceptibility; Susceptibilty 2.27 2.27                       0
54196-1 Mezlocillin+Sulbactam Susc Isolate Pt OrdQn Agar diffusion   ACTIVE Mezlocillin+Sulbactam [Susceptibility] by Disk diffusion (KB)   MIN DefinitionDescription                   ABXBACT   54196-1   Agar diffusion     Both       0 Mezlocillin+Sulbac Islt KB       N   ANTIBIOTIC SUSCEPTIBILITIES; AST; Baypen; Disk diffusion; ID; Infectious Disease; InfectiousDisease; Islt; Isol; KB; Kirby-bauer; Mezlin; Optocillin; Point in time; Random; Sulb; Sulbact; Sus; Suscept; Susceptibilities; Susceptibility; Susceptibilty 2.27 2.27                       0
54197-9 Piperacillin+Sulbactam Susc Isolate Pt OrdQn     ACTIVE Piperacillin+Sulbactam [Susceptibility]   MIN DefinitionDescription                   ABXBACT   54197-9         Both       0 Piperacillin+Sulbac Susc Islt       N   ANTIBIOTIC SUSCEPTIBILITIES; AST; ID; Infectious Disease; InfectiousDisease; Islt; Isol; Piper; PIPJ; Pipracil; Point in time; Random; Sulb; Sulbact; Sus; Suscept; Susceptibilities; Susceptibility; Susceptibilty 2.27 2.27                       0
54198-7 Piperacillin+Sulbactam Susc Isolate Pt OrdQn MIC   ACTIVE Piperacillin+Sulbactam [Susceptibility] by Minimum inhibitory concentration (MIC)   MIN DefinitionDescription                   ABXBACT   54198-7   MIC     Both       0 Piperacillin+Sulbac Islt MIC       N   ANTIBIOTIC SUSCEPTIBILITIES; AST; ID; Infectious Disease; InfectiousDisease; Islt; Isol; Minimum inhibitory concentration; Piper; PIPJ; Pipracil; Point in time; Random; Sulb; Sulbact; Sus; Suscept; Susceptibilities; Susceptibility; Susceptibilty 2.27 2.27                       0
54199-5 Piperacillin+Sulbactam Susc Isolate Pt OrdQn Agar diffusion   ACTIVE Piperacillin+Sulbactam [Susceptibility] by Disk diffusion (KB)   MIN DefinitionDescription                   ABXBACT   54199-5   Agar diffusion     Both       0 Piperacillin+Sulbac Islt KB       N   ANTIBIOTIC SUSCEPTIBILITIES; AST; Disk diffusion; ID; Infectious Disease; InfectiousDisease; Islt; Isol; KB; Kirby-bauer; Piper; PIPJ; Pipracil; Point in time; Random; Sulb; Sulbact; Sus; Suscept; Susceptibilities; Susceptibility; Susceptibilty 2.27 2.27                       0
542-1 Mycobacterium sp Prid Wound Pt Nom Organism specific culture   ACTIVE Mycobacterium sp identified in Wound by Organism specific culture   NAM DefinitionDescription                   MICRO   542-1   Organism specific culture     Both       0 Mycobacterium Wnd Cult           Acid Fast; Acid Fast Bacilli; Acid fast bacillus; AFB; C&S; Cult; Cultures; ID; Identity or presence; Infectious Disease; InfectiousDisease; Microbiology; Myco; Mycobact; Nominal; Point in time; Random; Spec; species; spp; Tuberculosis; Wnd 2.78 1                     Release 2.78: COMPONENT: Removed "Identified" from the component because it is implied by the Property "Prid"; 0
5420-5 CD105 ACnc WBC Pt Qn     DEPRECATED Deprecated CD105 cells/100 cells in Blood   MIN DefinitionDescription                   CELLMARK   5420-5                 0 Deprecated CD105 WBC-aCnc           Arbitrary concentration; CELL MARKERS; Endoglin; Leukocytes; Point in time; QNT; Quan; Quant; Quantitative; Random; WBCs; White blood cells 2.69 1       AssociatedObservations EXTERNAL_COPYRIGHT_LINK HL7_ATTACHMENT_STRUCTURE CONSUMER_NAME EXAMPLE_UCUM_UNITS STATUS_REASON STATUS_TEXT CHANGE_REASON_PUBLIC COMMON_TEST_RANK COMMON_ORDER_RANK
54200-1 Griseofulvin Susc Isolate Pt OrdQn     ACTIVE Griseofulvin [Susceptibility]   MIN DefinitionDescription                   ABXBACT   54200-1         Both       0 Griseofulvin Susc Islt       N   ANTIBIOTIC SUSCEPTIBILITIES; AST; ID; Infectious Disease; InfectiousDisease; Islt; Isol; Point in time; Random; Sus; Suscept; Susceptibilities; Susceptibility; Susceptibilty 2.27 2.27                       0
54201-9 Griseofulvin Susc Isolate Pt OrdQn MIC   ACTIVE Griseofulvin [Susceptibility] by Minimum inhibitory concentration (MIC)   MIN DefinitionDescription                   ABXBACT   54201-9   MIC     Both       0 Griseofulvin Islt MIC       N   ANTIBIOTIC SUSCEPTIBILITIES; AST; ID; Infectious Disease; InfectiousDisease; Islt; Isol; Minimum inhibitory concentration; Point in time; Random; Sus; Suscept; Susceptibilities; Susceptibility; Susceptibilty 2.73 2.27                       0
54202-7 Griseofulvin Susc Isolate Pt OrdQn Agar diffusion   ACTIVE Griseofulvin [Susceptibility] by Disk diffusion (KB)   MIN DefinitionDescription                   ABXBACT   54202-7   Agar diffusion     Both       0 Griseofulvin Islt KB       N   ANTIBIOTIC SUSCEPTIBILITIES; AST; Disk diffusion; ID; Infectious Disease; InfectiousDisease; Islt; Isol; KB; Kirby-bauer; Point in time; Random; Sus; Suscept; Susceptibilities; Susceptibility; Susceptibilty 2.27 2.27                       0
54203-5 Cefmenoxime Susc Isolate Pt OrdQn MIC   ACTIVE Cefmenoxime [Susceptibility] by Minimum inhibitory concentration (MIC)   MIN DefinitionDescription                   ABXBACT   54203-5   MIC     Both       0 Cefmenoxime Islt MIC       N   ANTIBIOTIC SUSCEPTIBILITIES; AST; Bestcall; Cefmax; Cefmenoxim; Cemix; ID; Infectious Disease; InfectiousDisease; Islt; Isol; Minimum inhibitory concentration; Point in time; Random; Sus; Suscept; Susceptibilities; Susceptibility; Susceptibilty; Tacef 2.27 2.27                       0
54204-3 Thiacetazone Susc Isolate Pt OrdQn MIC   ACTIVE Thiacetazone [Susceptibility] by Minimum inhibitory concentration (MIC)   MIN DefinitionDescription                   ABXBACT   54204-3   MIC     Both       0 Thiacetazone Islt MIC       N   Amithiozone; ANTIBIOTIC SUSCEPTIBILITIES; AST; ID; Infectious Disease; InfectiousDisease; Islt; Isol; Minimum inhibitory concentration; Point in time; Random; Sus; Suscept; Susceptibilities; Susceptibility; Susceptibilty; Thioacetazone 2.27 2.27                       0
54205-0 Legionella pneumophila 7+8+9+10+11+12+13+14 Ab Titr Ser Pt SemiQn     ACTIVE Legionella pneumophila 7+8+9+10+11+12+13+14 Ab [Titer] in Serum   MAJ DefinitionDescription     titer < 64 (Titre)           MICRO   54205-0         Both       0 L pneumo 7-14 Ab Titr Ser       N   ABS; Aby; Antby; Anti; Antibodies; Antibody; Autoantibodies; Autoantibody; Chicago 8; Dilution factor; Dilution Factor (Titer); ID; Infectious Disease; InfectiousDisease; L pneumo; L pneumo 7-14; L pneumo 7-14 Ab; L pneumo7; L pneumonphila; Legion; Legionela; Legionella pneumophila serogroup 7; Microbiology; Pneu; pneum; Pneumophilia; Point in time; Random; Serum; SmQn; SR; Titer; Titered; Titre; Ttr 2.75 2.27               {titer}       0
54206-8 Cytomegalovirus DNA LnCnc Ser/Plas Pt Qn Probe.amp.tar   ACTIVE Cytomegalovirus DNA [Log #/volume] (viral load) in Serum or Plasma by NAA with probe detection   MIN DefinitionDescription     log copies/mL             MICRO   54206-8   Probe.amp.tar     Both       0 CMV DNA SerPl NAA+probe-Log#       N   3 Self-Sustaining Sequence Replication; 3SR SR; Amplif; Amplification; Amplified; CMV; Cytomegalo virus; Cytomgal; Deoxyribonucleic acid; DNA NUCLEIC ACID PROBE; DNA probe; HHV-5; Human Herpesvirus-5; ID; Infectious Disease; InfectiousDisease; LAT; LCR; Ligase chain reaction; Ligation-activated transcription; Log NCNC; Log#; Microbiology; NAA+probe; NAAT; NASBA; Nucleic acid sequence based analysis; PCR; Pl; Plasma; Plsm; Point in time; Polymerase chain reaction; Probe amp; Probe with ampification; Probe with target amplification; QBR; QNT; Quan; Quant; Quantitative; Random; SDA; SerP; SerPl; SerPlas; Serum; Serum or plasma; SR; Strand Displacement Amplification; TMA; Transcription mediated amplification; Viral load 2.73 2.27               {Log_copies}/mL       0
104,672 results found